What is the P/E ratio of Mesco Pharmaceuticals?

The latest standalone P/E ratio of Mesco Pharmaceuticals as of 10-Jan-2022 is 0.00.

What is the P/B ratio of Mesco Pharmaceuticals?

The latest standalone P/B ratio of Mesco Pharmaceuticals as of 10-Jan-2022 is -0.88.

What is the 52-week high and low of Mesco Pharmaceuticals?

The 52-week high of Mesco Pharmaceuticals is Rs. 4.54 and the 52-week low is Rs. 4.54.

Mesco Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Mesco Pharmaceuticals
Brand: Mesco Pharmaceuticals

BSE: 500274 | NSE: MESCOPHARM | Pharmaceuticals & Drugs | Small Cap

Place order

DeciZen - make an informed investing decision on Mesco Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Mesco Pharmaceuticals stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

9.2 Cr.

52-wk low:

4.5

52-wk high:

4.5

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Mesco Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Mesco Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	TTM
ROCE % ⓘ	-8.4%	-0%	0%	-191.9%	3.4%	-109%	-36.3%	-176.1%	-45.8%	-2.1%	-
Value Creation Index ⓘ	-1.6	-1.0	-1.0	NA	-0.8	NA	NA	NA	NA	-1.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	0	0	0	0
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
Adj EPS ⓘ	-2.1	0	0	-22.7	0	-0.1	-0	-0.2	-0.1	0	0
YoY Gr.	-	NA	NA	NA	NA	-1400%	NA	NA	NA	NA	-
BVPS (₹) ⓘ	18.2	18.2	18.2	-5.2	-5.2	-5.3	-5.3	-5.5	-5.6	-5.6	-5.1
Adj Net Profit ⓘ	-4.2	0	0	-46.1	0	-0.3	-0.1	-0.4	-0.1	0	0
Cash Flow from Ops. ⓘ	-2.3	-0.2	0.7	-0.2	0	-0.3	-0.1	-0.4	-0.1	0	-
Debt/CF from Ops. ⓘ	-4.7	-48.9	16.7	-51.2	311.2	-40.3	-122.1	-28.3	-142.4	-5587.8	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	NA
Adj EPS ⓘ	NA	-100%	NA	NA
BVPSⓘ	-187.7%	NA	NA	NA
Share Price	-	-17.4%	-12.2%	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	TTM
Return on Equity % ⓘ	-11.2	-0	-0	-358	-0.2	2.5	0.8	3.8	0.9	0	0
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	NAN
Net Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	NAN
Debt to Equity ⓘ	0.3	0.3	0.3	-1.1	-1	-1	-1	-1	-1	-1	-
Working Cap Days ⓘ	0	0	0	0	0	0	0	0	0	0	0
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	0	0	0	0	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Mesco Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	-5.1	-
Reserves (₹ Cr.) ⓘ	-31	-
P/BV ⓘ	-0.88	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	4.54 / 4.54
All Time Low / High (₹)	0.60 / 58.00
Market Cap (₹ Cr.)	9.2
Equity (₹ Cr.)	20.3
Face Value (₹)	10
Industry PE ⓘ	48.5

Management X-Ray of Mesco Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Mesco Pharma

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Mesco Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Sales	0	0	0	0	0	0	0	0	0	0
Operating Expenses ⓘ	4.21	0	0	46.56	0.01	0.26	0.09	0.41	0.10	0
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	0	0	0	0	0	0.04	0.03	0	0	0
Other Costs ⓘ	4.21	0	0	46.56	0	0.22	0.06	0.41	0.10	0
Operating Profit ⓘ	-4.21	0	0	-46.56	-0.01	-0.26	-0.09	-0.41	-0.10	0
Operating Profit Margin (%)	-	-	-	-	-	-	-	-	-	-
Other Income ⓘ	0	0	0.03	0	0.04	0	0	0	0	0
Interest ⓘ	0.03	0	0.03	0.21	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-4.24	0	0	-46.76	0.03	-0.26	-0.09	-0.41	-0.10	0
Tax ⓘ	0	0	0	-0.63	0.01	0	0	0	0	0
Profit After Tax	-4.24	0	0	-46.14	0.02	-0.26	-0.09	-0.41	-0.10	0
PAT Margin (%)	-	-	-	-	-	-	-	-	-	-
Adjusted EPS (₹)	-2.2	0.0	0.0	-23.4	0.0	-0.1	0.0	-0.2	-0.1	0.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Equity and Liabilities
Shareholders Fund	35.96	35.96	35.96	-10.18	-10.16	-10.42	-10.51	-10.91	-11.01	-11.02
Share Capital ⓘ	19.74	19.74	19.74	19.74	19.74	19.74	19.74	19.74	19.74	19.74
Reserves ⓘ	16.22	16.22	16.22	-29.92	-29.90	-30.16	-30.24	-30.65	-30.75	-30.76
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	10.61	10.82	10.98	11.18	10.39	10.66	10.75	11.14	11.22	11.18
Long Term Debt	10.61	10.82	10.98	11.18	10.39	10.66	10.75	11.14	11.22	11.18
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Trade Payables	1.02	0.80	0.77	0	0	0.01	0.01	0.02	0.01	0.02
Others Liabilities ⓘ	0.63	0.63	0.63	0	0.01	0	0	0	0	0
Total Liabilities ⓘ	48.22	48.21	48.33	1	0.25	0.25	0.25	0.25	0.22	0.18
Fixed Assets
Gross Block	20.17	20.23	19.54	19.54	19.56	19.56	0.18	0.18	0.18	0.18
Accumulated Depreciation	0.36	0.42	0.42	19.38	19.38	19.38	0	0	0	0
Net Fixed Assetsⓘ	19.81	19.81	19.12	0.16	0.18	0.18	0.18	0.18	0.18	0.18
CWIP ⓘ	28.13	28.13	28.13	0	0	0	0	0	0	0
Investmentsⓘ	0.08	0.08	0.08	0.03	0.03	0.03	0.03	0.03	0	0
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0.10	0.10	0.10	0	0	0	0	0	0	0
Cash Equivalents	0.03	0.01	0.01	0	0.04	0.04	0.04	0.04	0.04	0
Others Assetsⓘ	0.07	0.07	0.88	0.81	0	0	0	0	0	0
Total Assets ⓘ	48.22	48.21	48.33	1	0.25	0.25	0.25	0.25	0.22	0.18

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Cash Flow From Operating Activity ⓘ	-2.27	-0.22	0.66	-0.22	0.03	-0.26	-0.09	-0.39	-0.08	0
PBT ⓘ	-4.24	0	0	-46.76	0.03	-0.26	-0.09	-0.41	-0.10	0
Adjustment ⓘ	0	0	0.69	46.56	0	0	0	0	0.03	0
Changes in Working Capital ⓘ	1.97	-0.22	-0.03	-0.01	0.01	-0.01	-0	0.02	-0.01	0
Tax Paid ⓘ	0	0	0	0	-0.01	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	5	0	0	0	-0.02	0	0	0	0	0
Capex	0	0	0	0	-0.02	0	0	0	0	0
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	5	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	-2.73	0.21	-0.66	0.21	0.02	0.26	0.09	0.39	0.08	-0.03
Net Proceeds from Shares ⓘ	-2.73	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0.39	0.08	-0.03
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0.21	-0.66	0.21	0.02	0.26	0.09	0	0	0
Net Cash Flow ⓘ	0	-0.01	0	-0.01	0.04	0	0	0	0	-0.04

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Ratios
ROE (%)	-11.15	-0.01	-0.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ROCE (%)	-8.42	-0.01	0.07	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0	0	0	0	0	0	0	0	0	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	1.5	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Mesco Pharmaceuticals Ltd Stock News

Mesco Pharmaceuticals Ltd FAQs

What is the share price of Mesco Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Mesco Pharma on 10-Jan-2022 18:01 is ₹4.54.

What is the market cap of Mesco Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Jan-2022 18:01 the market cap of Mesco Pharma stood at ₹9.23.

What is the P/E ratio of Mesco Pharma?

The latest P/E ratio of Mesco Pharma as of 10-Jan-2022 18:01 is 0.00.

What is the P/B ratio of Mesco Pharma?

The latest P/B ratio of Mesco Pharma as of 10-Jan-2022 18:01 is -0.88.

What is the 52-week high and low of Mesco Pharma?

The 52-week high of Mesco Pharma is ₹4.54 and the 52-week low is ₹4.54.

What is the TTM revenue of Mesco Pharma?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mesco Pharma is ₹0.00 ( Cr.) .

About Mesco Pharmaceuticals Ltd

Mesco Pharmaceuticals Ltd is Public Limited Company listed with Bombay Stock Exchange Limited, Calcutta Stock Exchange and Ahmedabad Stock Exchange, established in 1986.

The Company was originally promoted and incorporated as public limited company under the provisions of Companies Act, 1956 under the jurisdiction of Registrar of Companies, Sri Nagar. The Registered office of the Company is shifted from Jammu and Kashmir to Uttar Pradesh on November 10, 1993. At Present the Registered Office of the Company is situated at Upper Kesalton, Tallital, Nainital-263 001, Uttarakhand.

The Company commenced commercial operations in June 1991 by venturing into Seed Marketing of Bulk Drugs and Formalities. However, the operations of the company came to a standstill for more than 15 years due to taking over of the factory building and other assets of the company in Dehradun by UP State Financial Corporation. Though, the Board of the Company is in the process of evaluating alternative business opportunities which the company may choose to enter into the future.

Business area of the company

The company manufactures and distributes a wide range of pharmaceutical products. The Company manufactures bulk drugs and formulations which are sold domestically in India and abroad. However, the business activity of the company was closed since many years.